Delivery Order SPE2DB25D3006-SPE2DB25FXKLM
- Not listed
- The Defense Logistics Agency awarded a $1,781.31 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lyrica 200 mg capsules (90-count units). This firm fixed-price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.999 billion through December 2026. The place of performance is AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) valued at $2,530.67. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was awarded competitively with no set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract value of $3,157.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 16, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lyrica 100 mg capsules (quantity: 90 units) with a ceiling value of $2,514.26. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract is scheduled for ultimate completion on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $1,853.49. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is non-competitive and issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lyrica 100 mg capsules (90 count) with a contract value of $4,272.77. This is a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract ceiling value of $4,142.53. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,580.34 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units). This firm fixed price, competitively awarded contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This non-set-aside, competitively awarded contract employs firm fixed price terms with an ultimate completion date of August 27, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.94 to AmerisourceBergen Drug Corp for 90-count bottles of Lyrica 300 mg capsules. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division. The...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXKLMDelivery Order
The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's headquarters location in Conshohocken, Pennsylvania, with a completion date of September 17, 2025. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Lyrica order represents a typical transaction within the company's extensive pharmaceutical portfolio managed through the DLA Troop Support Medical contract vehicle, which enables AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order carries no set-aside designation, demonstrating the company's capability to compete successfully in open federal pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/16/25 |